Liang L, Kuang X, He Y, Zhu L, Lau P, Li X
Nat Genet. 2025; 57(3):680-693.
PMID: 40069506
PMC: 11906371.
DOI: 10.1038/s41588-025-02077-6.
Eserhaut D, DeLeo J, Provost J, Ackerman K, Fry A
Front Physiol. 2025; 16:1538465.
PMID: 40034535
PMC: 11873099.
DOI: 10.3389/fphys.2025.1538465.
Bender A, Ranea-Robles P, Williams E, Williams E, Mirzaian M, Heimel J
bioRxiv. 2025; .
PMID: 40027804
PMC: 11870498.
DOI: 10.1101/2025.02.19.639093.
Sun Q, Karwi Q, Wong N, Lopaschuk G
Cardiovasc Res. 2024; 120(16):1996-2016.
PMID: 39453987
PMC: 11646102.
DOI: 10.1093/cvr/cvae231.
Engin A
Adv Exp Med Biol. 2024; 1460:131-166.
PMID: 39287851
DOI: 10.1007/978-3-031-63657-8_5.
Metabolic features of neutrophilic differentiation of HL-60 cells in hyperglycemic environments.
Cazares-Preciado J, Lopez-Arredondo A, Cruz-Cardenas J, Luevano-Martinez L, Garcia-Rivas G, Prado-Garcia H
BMJ Open Diabetes Res Care. 2024; 12(4).
PMID: 39122366
PMC: 11409339.
DOI: 10.1136/bmjdrc-2024-004181.
AMPK targets PDZD8 to trigger carbon source shift from glucose to glutamine.
Li M, Wang Y, Wei X, Cai W, Wu J, Zhu M
Cell Res. 2024; 34(10):683-706.
PMID: 38898113
PMC: 11442470.
DOI: 10.1038/s41422-024-00985-6.
Metabolic Dysfunction-Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options.
Portincasa P, Khalil M, Mahdi L, Perniola V, Idone V, Graziani A
Int J Mol Sci. 2024; 25(11).
PMID: 38891828
PMC: 11172019.
DOI: 10.3390/ijms25115640.
Overnutrition, Hyperinsulinemia and Ectopic Fat: It Is Time for A Paradigm Shift in the Management of Type 2 Diabetes.
Janssen J
Int J Mol Sci. 2024; 25(10).
PMID: 38791525
PMC: 11121669.
DOI: 10.3390/ijms25105488.
Effects of a 10-Week Exercise and Nutritional Intervention with Variable Dietary Carbohydrates and Glycaemic Indices on Substrate Metabolism, Glycogen Storage, and Endurance Performance in Men: A Randomized Controlled Trial.
Moitzi A, Krssak M, Klepochova R, Triska C, Csapo R, Konig D
Sports Med Open. 2024; 10(1):36.
PMID: 38600291
PMC: 11006643.
DOI: 10.1186/s40798-024-00705-9.
Lipid Metabolism in Metabolic-Associated Steatotic Liver Disease (MASLD).
Syed-Abdul M
Metabolites. 2024; 14(1).
PMID: 38248815
PMC: 10818604.
DOI: 10.3390/metabo14010012.
17β-Estradiol (E) Upregulates the ERα/SIRT1/PGC-1α Signaling Pathway and Protects Mitochondrial Function to Prevent Bilateral Oophorectomy (OVX)-Induced Nonalcoholic Fatty Liver Disease (NAFLD).
Tian Y, Hong X, Xie Y, Guo Z, Yu Q
Antioxidants (Basel). 2023; 12(12).
PMID: 38136219
PMC: 10740447.
DOI: 10.3390/antiox12122100.
Pharmacologic inhibition of lipogenesis for the treatment of NAFLD.
Esler W, Cohen D
J Hepatol. 2023; 80(2):362-377.
PMID: 37977245
PMC: 10842769.
DOI: 10.1016/j.jhep.2023.10.042.
Hepatic FASN deficiency differentially affects nonalcoholic fatty liver disease and diabetes in mouse obesity models.
Matsukawa T, Yagi T, Uchida T, Sakai M, Mitsushima M, Naganuma T
JCI Insight. 2023; 8(17).
PMID: 37681411
PMC: 10544238.
DOI: 10.1172/jci.insight.161282.
The proteasome regulates body weight and systemic nutrient metabolism during fasting.
Langer H, Taylor S, Ahmed M, Perrier T, Ahmed T, Goncalves M
Am J Physiol Endocrinol Metab. 2023; 325(5):E500-E512.
PMID: 37672249
PMC: 10864006.
DOI: 10.1152/ajpendo.00069.2023.
Longer-Term Effects of the Glycaemic Index on Substrate Metabolism and Performance in Endurance Athletes.
Moitzi A, Konig D
Nutrients. 2023; 15(13).
PMID: 37447354
PMC: 10347093.
DOI: 10.3390/nu15133028.
Pharmacotherapies of NAFLD: updated opportunities based on metabolic intervention.
Shao Y, Chen S, Han L, Liu J
Nutr Metab (Lond). 2023; 20(1):30.
PMID: 37415199
PMC: 10327300.
DOI: 10.1186/s12986-023-00748-x.
Nutrient sensors and their crosstalk.
Sung Y, Yu Y, Han J
Exp Mol Med. 2023; 55(6):1076-1089.
PMID: 37258576
PMC: 10318010.
DOI: 10.1038/s12276-023-01006-z.
Metabolic sensing and control in mitochondria.
Liu Y, Birsoy K
Mol Cell. 2023; 83(6):877-889.
PMID: 36931256
PMC: 10332353.
DOI: 10.1016/j.molcel.2023.02.016.
Persistent fasting lipogenesis links impaired ketogenesis with citrate synthesis in humans with nonalcoholic fatty liver.
Fu X, Fletcher J, Deja S, Inigo-Vollmer M, Burgess S, Browning J
J Clin Invest. 2023; 133(9).
PMID: 36928190
PMC: 10145942.
DOI: 10.1172/JCI167442.